Colchicintherapie nach MyokardinfarktColchicine Cardiovascular Outcomes Trial (COLCOT)Colchicine treatment after myocardial infarctionColchicine Cardiovascular Outcomes Trial (COLCOT)

被引：0
|
作者：
R. Klingenberg
S. Nitschmann
机构：
[1] Campus Kerckhoff der Justus-Liebig-Universität Gießen,Abteilung Kardiologie, Kerckhoff
来源：
Der Internist | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：766 / 769
页数：3
相关论文
共 50 条
  • [21] IMPACT OF INDIVIDUAL TREATMENT STRATEGIES ON COMPOSITE AND INDIVIDUAL CARDIOVASCULAR OUTCOMES IN THE AFFIRM TRIAL
    Slee, April
    Rathod, Snehal
    Verma, Ankush
    Liu, Tina
    Saksena, Sanjeev
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [22] Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
    Caterson, I. D.
    Finer, N.
    Coutinho, W.
    Van Gaal, L. F.
    Maggioni, A. P.
    Torp-Pedersen, C.
    Sharma, A. M.
    Legler, U. F.
    Shepherd, G. M.
    Rode, R. A.
    Perdok, R. J.
    Renz, C. L.
    James, W. P. T.
    DIABETES OBESITY & METABOLISM, 2012, 14 (06): : 523 - 530
  • [23] Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial
    O'Donoghue, Michelle L.
    Glaser, Ruchira
    Cavender, Matthew A.
    Aylward, Philip E.
    Bonaca, Marc P.
    Budaj, Andrzej
    Davies, Richard Y.
    Dellborg, Mikael
    Fox, Keith A. A.
    Gutierrez, Jorge Antonio T.
    Hamm, Christian
    Kiss, Robert G.
    Kovar, Frantisek
    Kuder, Julia F.
    Im, Kyung Ah
    Lepore, John J.
    Lopez-Sendon, Jose L.
    Ophuis, Ton Oude
    Parkhomenko, Alexandr
    Shannon, Jennifer B.
    Spinar, Jindrich
    Tanguay, Jean-Francois
    Ruda, Mikhail
    Steg, P. Gabriel
    Theroux, Pierre
    Wiviott, Stephen D.
    Laws, Ian
    Sabatine, Marc S.
    Morrow, David A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15): : 1591 - 1599
  • [24] Cardiovascular outcomes trial with anacetrapib in subjects with high cardiovascular risk - are major benefits REVEALed?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (06) : 611 - 615
  • [25] Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis
    Sinnaeve, Peter R.
    Schwartz, Gregory G.
    Wojdyla, Daniel M.
    Alings, Marco
    Bhatt, Deepak L.
    Bittner, Vera A.
    Chiang, Chern-En
    Flores, Roger M. Correa
    Diaz, Rafael
    Dorobantu, Maria
    Goodman, Shaun G.
    Jukema, J. Wouter
    Kim, Yong-Un
    Pordy, Robert
    Roe, Matthew T.
    Sy, Rody G.
    Szarek, Michael
    White, Harvey D.
    Zeiher, Andreas M.
    Steg, Ph Gabriel
    EUROPEAN HEART JOURNAL, 2020, 41 (24) : 2248 - 2258
  • [26] History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial
    Lewis, Cora E.
    Bantle, John P.
    Bertoni, Alain G.
    Blackburn, George
    Brancati, Frederick L.
    Bray, George A.
    Cheskin, Lawrence J.
    Curtis, Jeffrey M.
    Egan, Caitlin
    Evans, Mary
    Foreyt, John P.
    Ghazarian, Siran
    Barone Gibbs, Bethany
    Glasser, Stephen P.
    Gregg, Edward W.
    Hazuda, Helen P.
    Hesson, Louise
    Hill, James O.
    Horton, Edward S.
    Hubbard, Van S.
    Jakicic, John M.
    Jeffery, Robert W.
    Johnson, Karen C.
    Kahn, Steven E.
    Kitabchi, Abbas E.
    Kitzman, Dalane
    Knowler, William C.
    Lipkin, Edward
    Michaels, Sara
    Montez, Maria G.
    Nathan, David M.
    Nyenwe, Ebenezer
    Patricio, Jennifer
    Peters, Anne
    Pi-Sunyer, Xavier
    Pownall, Henry
    Reboussin, David M.
    Ryan, Donna H.
    Wadden, Thomas A.
    Wagenknecht, Lynne E.
    Wyatt, Holly
    Wing, Rena R.
    Yanovski, Susan Z.
    OBESITY, 2020, 28 (02) : 247 - 258
  • [27] Cardiovascular Outcomes Trials Update: Insights from the DEVOTE Trial
    Bilal, Anika
    Pratley, Richard E.
    CURRENT DIABETES REPORTS, 2018, 18 (11)
  • [28] Rosiglitazone evaluated for cardiovascular outcomes: An interim analysis of the RECORD trial
    L. Romayne Kurukulasuriya
    Samy I. McFarlane
    Current Cardiovascular Risk Reports, 2008, 2 (2) : 85 - 87
  • [29] Rationale and Design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
    Bethel, M. Angelyn
    Green, Jennifer
    Califf, Robert M.
    Holman, Rury R.
    DIABETES, 2009, 58 : A555 - A555
  • [30] Impact of established cardiovascular disease on outcomes in the Global Leaders trial
    Garg, S.
    Chichareon, P.
    Modolo, R.
    Tomaniak, M.
    Serra-Penaranda, A.
    Curello, S.
    Mlodziankowski, A.
    Hamm, C.
    Steg, G.
    Juni, P.
    Vranckx, P.
    Valgimigli, M.
    Windecker, S.
    Onuma, Y.
    Serruys, P. W. J. C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3108 - 3108
12345